Breakthrough study finds single dose of psychedelics significantly reduced depression symptoms in clinical trial, with effects lasting up to six months.

A new study found that people with depression and anxiety who used GLP-1 drugs like Ozempic and Wegovy had a 42% lower risk ...

Psilocybin, the main psychoactive ingredient in magic mushrooms, could alleviate depression for at least five years after just one dose, according to a new study. The research, presented June 18 at ...

A large multi-site naturalistic study evaluated an integrated behavioral health care model offering medication management, psychotherapy, and transcranial magnetic stimulation (TMS) at all Family Care ...

Psilocybin, the main psychoactive ingredient in magic mushrooms, could alleviate depression for at least five years after just one dose, according to a new study. The research, presented June 18 at ...

Learn more about a clinical trial examining a potential new treatment for depression in adult patients. Managing symptoms of depression can feel overwhelming, but you are not alone. If you experience ...

Is paternal postnatal depression delayed? New research finds a 30% increase in depression and stress diagnoses for fathers ...

The study, published on Friday in the journal Science, addresses a critical global health issue: nearly 60 percent of ...

This phenomenon can distort the results of psychedelic drug trials. While a placebo in a traditional antidepressant drug ...

Fathers in Sweden are less likely to receive a psychiatric diagnosis during their partner's pregnancy and in the months ...

A novel analysis of more than 375 published studies concluded that the association between chronic pain and rates of depression and anxiety is staggering. The study found that 40% of adults with ...

New genetic risk factors for depression have been identified across all major global populations for the first time, allowing scientists to predict risk of depression regardless of ethnicity. The ...